Integrating Program Assessment and a Career Focus into a Research Methods Course

2017 ◽  
Vol 45 (2) ◽  
pp. 131-141 ◽  
Author(s):  
Mary Scheuer Senter

Sociology research methods students in 2013 and 2016 implemented a series of “real world” data gathering activities that enhanced their learning while assisting the department with ongoing program assessment and program review. In addition to the explicit collection of program assessment data on both students’ development of sociological concepts and skills while undergraduates and alumni’s use of such knowledge after graduation, an effort was made throughout the semesters to highlight key research methods knowledge using examples that focused on job searching and careers appropriate for baccalaureate-trained sociologists. Students reported that these real-world activities both increased their interest in and their learning about research methods. These explicit and implicit experiences with an employment focus also led them to increase their own thinking about their eventual careers and preparing job search materials, such as résumés, that include skills developed in their undergraduate sociology courses.

1987 ◽  
Vol 18 (2) ◽  
pp. 109-113
Author(s):  
O. Harari ◽  
D. T. Beaty

This article extends the argument put forward by Orpen (1985), that management researchers should consider the validity of the model used by applied research practitioners. Given the increasing complexity of issues affecting management and shop-floor workers in South Africa, this paper raises several problems of methodology that researchers applying the traditional 'scientific model' of research are likely to face. The authors draw on their personal experiences in conducting 'applied research', to suggest some solutions to the problems they have raised. The article concludes by suggesting that the 'scientific' model should be the foundation of applied research, but the architecture on top needs to be fitted to the messy and untidy complexities of real-world data-gathering.


2016 ◽  
Vol 22 ◽  
pp. 219
Author(s):  
Roberto Salvatori ◽  
Olga Gambetti ◽  
Whitney Woodmansee ◽  
David Cox ◽  
Beloo Mirakhur ◽  
...  

VASA ◽  
2019 ◽  
Vol 48 (2) ◽  
pp. 134-147 ◽  
Author(s):  
Mirko Hirschl ◽  
Michael Kundi

Abstract. Background: In randomized controlled trials (RCTs) direct acting oral anticoagulants (DOACs) showed a superior risk-benefit profile in comparison to vitamin K antagonists (VKAs) for patients with nonvalvular atrial fibrillation. Patients enrolled in such studies do not necessarily reflect the whole target population treated in real-world practice. Materials and methods: By a systematic literature search, 88 studies including 3,351,628 patients providing over 2.9 million patient-years of follow-up were identified. Hazard ratios and event-rates for the main efficacy and safety outcomes were extracted and the results for DOACs and VKAs combined by network meta-analysis. In addition, meta-regression was performed to identify factors responsible for heterogeneity across studies. Results: For stroke and systemic embolism as well as for major bleeding and intracranial bleeding real-world studies gave virtually the same result as RCTs with higher efficacy and lower major bleeding risk (for dabigatran and apixaban) and lower risk of intracranial bleeding (all DOACs) compared to VKAs. Results for gastrointestinal bleeding were consistently better for DOACs and hazard ratios of myocardial infarction were significantly lower in real-world for dabigatran and apixaban compared to RCTs. By a ranking analysis we found that apixaban is the safest anticoagulant drug, while rivaroxaban closely followed by dabigatran are the most efficacious. Risk of bias and heterogeneity was assessed and had little impact on the overall results. Analysis of effect modification could guide the clinical decision as no single DOAC was superior/inferior to the others under all conditions. Conclusions: DOACs were at least as efficacious as VKAs. In terms of safety endpoints, DOACs performed better under real-world conditions than in RCTs. The current real-world data showed that differences in efficacy and safety, despite generally low event rates, exist between DOACs. Knowledge about these differences in performance can contribute to a more personalized medicine.


1987 ◽  
Vol 32 (2) ◽  
pp. 170-170
Author(s):  
William J. Froming

Sign in / Sign up

Export Citation Format

Share Document